TokenPost·
Biodesix Plans 2026 Revenue of $101 Million to $103 Million, About 115 Sales Reps
Third-quarter total revenue rose 10%, while diagnostic testing revenue increased 16% and test volumes grew 24%. Gross margin was 81%.
More news
- TokenPostKaia Sets Nov. 17 Start Date for Manual Staking Migration
- TokenPostSamsung Electronics Co-CEO 卢泰文 Buys 3,000 Shares for 630 Million Won
- TokenPostVentas Realty Prices $500 Million of 5.5% Notes Due in 2033
- TokenPostAnthropic Models Gained Capabilities Nearly Twice as Fast by October
- Bitcoin.com NewsMichael Saylor Reveals 400-Year History Behind Bitcoin Income
- TokenPostSpot Bitcoin and Ether Funds Shed $530 Million in One Day